SCHEMBL3315920

SCHEMBL3315920

O=c1[nH]ccc2cc(N[C@H]3CCN(C4CCCCC4)C3)ccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 1/20 0.41
KIT P10721 1/20 0.38
FLT3 P36888 1/20 0.38
ROCK2 O75116 7/20 0.38
ROCK1 Q13464 7/20 0.37
PRKACA P17612 4/20 0.37
PRKCD Q05655 2/20 0.37
PRKG1 Q13976 1/20 0.37
PKN1 Q16512 1/20 0.37
PKN2 Q16513 1/20 0.37
AAK1 Q2M2I8 1/20 0.37
CDC42BPA Q5VT25 1/20 0.37
Q6ZSR9 Q6ZSR9 1/20 0.37
BMP2K Q9NSY1 1/20 0.37
CDC42BPB Q9Y5S2 1/20 0.37
PRKX P51817 1/20 0.37
PRKCE Q02156 1/20 0.37
PRKD1 Q15139 1/20 0.37
PRKACG P22612 3/20 0.37
PRKACB P22694 3/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3315923 1.00 IP6K1 (0.41) IP6K1KITFLT3ROCK2ROCK1
SCHEMBL3309378 0.94 IP6K1 (0.43) IP6K1KITFLT3ROCK2ROCK1
SCHEMBL3309366 0.94 IP6K1 (0.43) IP6K1KITFLT3ROCK2ROCK1
SCHEMBL3311595 0.92 IP6K1 (0.44) IP6K1KITFLT3ROCK2ROCK1
SCHEMBL3311544 0.82 PRKACA (0.41) IP6K1ROCK2ROCK1PRKACAPRKACG
SCHEMBL3311535 0.82 PRKACA (0.41) IP6K1ROCK2ROCK1PRKACAPRKACG
SCHEMBL3314198 0.79 ROCK2 (0.42) KITFLT3ROCK2ROCK1PRKACA
SCHEMBL3314191 0.79 ROCK2 (0.42) KITFLT3ROCK2ROCK1PRKACA
SCHEMBL25834155 0.79 KIT (0.52) IP6K1KITFLT3ROCK2ROCK1
SCHEMBL3316992 0.79 ROCK2 (0.46) IP6K1ROCK2ROCK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8748614-B2 Substituted isoquinoline and isoquinolinone derivatives SANOFI (FR) 2014-06-10 US disclosed
US-8748614-B2 Substituted isoquinoline and isoquinolinone derivatives SANOFI (FR) 2014-06-10 US disclosed
US-8748614-B2 Substituted isoquinoline and isoquinolinone derivatives SANOFI (FR) 2014-06-10 US disclosed
US-20100105650-A1 Substituted isoquinoline and isoquinolinone derivatives SANOFI-AVENTIS (FR) 2010-04-29 US disclosed
US-20100105650-A1 Substituted isoquinoline and isoquinolinone derivatives SANOFI-AVENTIS (FR) 2010-04-29 US disclosed
US-20100105650-A1 Substituted isoquinoline and isoquinolinone derivatives SANOFI-AVENTIS (FR) 2010-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100105650-A1 Substituted isoquinoline and isoquinolinone derivatives MYLK2, MYLK, MYLK3 IP6K1 135/4885KIT 3111/4885FLT3 3672/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.